Joined January 2010
- Tweets 5
- Following 31
- Followers 9
- Likes 9
Photos and videos
John Santini retweeted
Vergent Bioscience names Adam Gridley President & CEO. John Santini, PhD, moves to CTO to lead platform expansion as we advance a Phase 3 study evaluating abenacianine for tumor visualization during lung cancer surgery.
Read more: bit.ly/43kDXu7
#Leadership
1
1
3
61
13 Dec 2023
The VISUALIZE study is an exciting next step for VGT-309 and we look forward to further evaluating its utility in lung cancer surgery.
13 Dec 2023
#NEWS: The first patients have been enrolled in our Phase 2 multi-center VISUALIZE study! The study will assess the potential of our tumor-targeted fluorescent imaging agent, VGT-309, to improve visibility of tumors during lung cancer surgery. Read more: vergentbio.com/vergent-bio-i…
#clinicaltrials #medtwitter #meded
1
25
11 Sep 2023
It was great to have so many attendees at Dr. Wright's presentation of phase 2 VGT-309 study data earlier today. #WCLC23 @IASLC
11 Sep 2023
Today we presented new data at the @IASLC 2023 World Conference on #LungCancer providing compelling evidence that VGT-309 increases the potential that surgeons can identify all tumor tissue during minimally invasive and robotic surgery. #WLCL23 Read more: vergentbio.com/news-2023-sep…
ALT John Santini, CEO Quote Card
4
146
29 Nov 2022
We are grateful to the NCI and the team at Penn for their support of our Phase 2 trial of VGT-309 in lung cancer.
29 Nov 2022
We’ve been awarded a Small Business #Innovation Research grant from @NIH.
This will support our study of targeted fluorescent imaging agent to improve #tumorvisualization.
Read the announcement: bit.ly/3OHWEzL
3
4 Oct 2022
Previous clinical studies have validated the potential of VGT-309, and these additional funds will enable us to efficiently advance our current and future clinical trials in #LungCancer.
4 Oct 2022
Vergent Bioscience Secures $21.5 Million Series B Financing to Advance Clinical Development of Tumor-Targeted Fluorescent Imaging Agent VGT-309.
Read the full media release: bit.ly/3M4rLUI
#innovation #tumorvisualization
1
2